港股醫療器械股走強 愛康醫療和春立醫療漲超10%
格隆匯4月21日丨港股市場此前持續回調的醫療器械股今日集體走強,其中,愛康醫療和春立醫療盤中均漲超10%,永勝醫療、現代牙科、康基醫療、先健科技和心通醫療均漲明顯上漲。近日印度、日本和韓國的疫情加劇,二級市場上以疫苗和醫療器械為主的抗疫概念股目前有所表現。另外,歐盟委員會昨日在一份公吿中稱,鑑於歐盟成員國抗擊新冠肺炎疫情仍面臨挑戰,從第三國進口醫療設備和個人防護裝備仍十分重要,歐盟決定將免税有效期從今年的4月30日延至12月31日,從而繼續為成員國提供財政支持,幫助醫護人員和患者獲取口罩、呼吸機等急需的抗疫物資。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.